CNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q4 2023

Centessa Pharmaceuticals Surpasses Expectations

Centessa Pharmaceuticals (NASDAQ:CNTA) recently revealed their performance for the fourth quarter of 2023.

Strong Earnings Report

• The company’s earnings per share stood at -38 cents, surpassing the analysts’ forecast of -48 cents.
• Centessa Pharmaceuticals also disclosed revenue amounting to $6.85 million.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.